FORMA CRISTALINA DE TAZOFELONA((+,-)-5-((3,5-BIS(1,1-DIMETILETIL)-4-HIDROXIFENIL)METIL)-4-TIAZOLIDINONA)

FORMA CRISTALINA DE TAZOFELONA((+,-)-5-((3,5-BIS(1,1-DIMETILETIL)-4-HIDROXIFENIL)METIL)-4-TIAZOLIDINONA)

The instant invention provides novel crystalline Form II of (+/-)-5-äÄ3,5-bis(1,1-dimethylethyl)-4-hydroxyphenylÜmethylü-4-thiazol idinone having an x-ray powder diffraction pattern with d spacings at 5.64 ANGSTROM , 5.16 ANGSTROM , 4.90 ANGSTROM , 4.66 ANGSTROM and 4.49 ANGSTROM is useful for treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ALLEN ROBERT HARKNESS, SUSAN MARIE REUTZEL, MARVIN MARTIN HANSEN
Format: Patent
Sprache:por
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The instant invention provides novel crystalline Form II of (+/-)-5-äÄ3,5-bis(1,1-dimethylethyl)-4-hydroxyphenylÜmethylü-4-thiazol idinone having an x-ray powder diffraction pattern with d spacings at 5.64 ANGSTROM , 5.16 ANGSTROM , 4.90 ANGSTROM , 4.66 ANGSTROM and 4.49 ANGSTROM is useful for treating inflammation, inflammatory bowel disease, allergies, arthritis and hypoglycemia utilizing the novel physical form as well as pharmaceutical compositions containing the same. A process for preparing Form II Tazofelone is described.